nach oben

International Urology and Nephrology

Erschienen in:

01.03.2016 | Urology - Review

IgG4-related disease: what urologists should know

verfasst von: Daniele Bianchi

Erschienen in: International Urology and Nephrology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

IgG4-related disease (IgG4-RD) is a recent nosological entity defined as a chronic immune-mediated fibro-inflammatory condition characterized by a tendency to form tumefactive, tissue-destructive lesions or by organ failure. Urologic involvement in IgG4-RD has been described in some short series of patients and in isolated case reports.

Aim

The aim of the present study was to review urologic involvement in IgG4-RD with the purpose of providing urologists with the proper background necessary for a preliminary assessment of possible urologic localization of this recent clinical entity. Indeed, patients are typically referred for immunologic management, often right after a differential diagnosis of urologic disease.

Materials and methods

A systematic search of PubMed^® for both original and review articles published up until October 2015 was performed using keywords relating to IgG4 and to single specific urologic organs, structures, or anatomic sites. The search was then extended to Google^® using the same search criteria in order to identify articles not indexed in PubMed^®.

Results

IgG4-RD is a systemic condition potentially involving every urologic site. It can mimic malignancies and is often misdiagnosed due to its rarity.

Conclusions

A multidisciplinary approach to IgG4-RD should be required because it occasionally mimics other urologic diseases, including malignancies. Therefore, urologists should perform preliminary assessments to avoid inappropriate urologic treatments.

Wallace ZS, Stone JH (2015) An update on IgG4-related disease. Curr Opin Rheumatol 27(1):83–90. doi:10.1097/BOR.0000000000000133 CrossRefPubMed

Carruthers MN, Stone JH, Khosroshahi A (2012) The latest on IgG4-RD: a rapidly emerging disease. Curr Opin Rheumatol 24(1):60–69. doi:10.1097/BOR.0b013e32834ddb4a CrossRefPubMed

Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D, Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 Team (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22(1):1–14. doi:10.1007/s10165-011-0508-6 PubMedCentralCrossRefPubMed

Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers M, Chari S, Della-Torre E, Frulloni L, Goto H, Hart P, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Löhr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T et al (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67(7):1688–1699. doi:10.1002/art.39132 CrossRefPubMed

Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Klöppel G, Heathcote JG, Khosroshahi A, Ferry JA, Aalberse RC, Bloch DB, Brugge WR, Bateman AC, Carruthers MN, Chari ST, Cheuk W, Cornell LD, Fernandez-Del Castillo C, Forcione DG, Hamilos DL et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181–1192. doi:10.1038/modpathol.2012.72 CrossRefPubMed

Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40(7):1561–1568CrossRefPubMed

Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344(10):732–738CrossRefPubMed

Kamisawa T (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38(10):982–984CrossRefPubMed

Guma M, Firestein GS (2012) IgG4-related diseases. Best Pract Res Clin Rheumatol 26(4):425–438. doi:10.1016/j.berh.2012.07.001 CrossRefPubMed

10.

Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22(1):21–30. doi:10.1007/s10165-011-0571-z CrossRefPubMed

11.

Khosroshahi A, Stone JH (2011) A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 23(1):57–66. doi:10.1097/BOR.0b013e3283418057 CrossRefPubMed

12.

Uchiyama-Tanaka Y, Mori Y, Kimura T, Sonomura K, Umemura S, Kishimoto N, Nose A, Tokoro T, Kijima Y, Yamahara H, Nagata T, Masaki H, Umeda Y, Okazaki K, Iwasaka T (2004) Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis 43(3):e18–e25CrossRefPubMed

13.

Takeda S, Haratake J, Kasai T, Takaeda C, Takazakura E (2004) IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant 19(2):474–476CrossRefPubMed

14.

Kawano M, Mizushima I, Yamaguchi Y, Imai N, Nakashima H, Nishi S, Hisano S, Yamanaka N, Yamamoto M, Takahashi H, Umehara H, Saito T, Saeki T (2012) Immunohistochemical characteristics of IgG4-related tubulointerstitial nephritis: detailed analysis of 20 Japanese cases. Int J Rheumatol 2012:609795. doi:10.1155/2012/609795 PubMedCentralPubMed

15.

Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, Bhalodia A, Sohani AR, Zhang L, Chari S, Sethi S, Fidler ME, Cornell LD (2011) Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 22(7):1343–1352. doi:10.1681/ASN.2011010062 PubMedCentralCrossRefPubMed

16.

Cornell LD, Chicano SL, Deshpande V, Collins AB, Selig MK, Lauwers GY, Barisoni L, Colvin RB (2007) Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol 31(10):1586–1597CrossRefPubMed

17.

Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, Yamamoto M, Takahashi H, Matsui S, Nakada S, Origuchi T, Hirabayashi A, Homma N, Tsubata Y, Takata T, Wada Y, Saito A, Fukase S, Ishioka K, Miyazaki K, Masaki Y, Umehara H, Sugai S, Narita I (2010) Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int 78(10):1016–1023. doi:10.1038/ki.2010.271 CrossRefPubMed

18.

Watson SJ, Jenkins DA, Bellamy CO (2006) Nephropathy in IgG4-related systemic disease. Am J Surg Pathol 30(11):1472–1477CrossRefPubMed

19.

Morimoto J, Hasegawa Y, Fukushima H, Uesugi N, Hisano S, Saito T, Kaneoka H (2009) Membranoproliferative glomerulonephritis-like glomerular disease and concurrent tubulointerstitial nephritis complicating IgG4-related autoimmune pancreatitis. Intern Med 48(3):157–162CrossRefPubMed

20.

Cornell LD (2012) IgG4-related kidney disease. Curr Opin Nephrol Hypertens 21(3):279–288. doi:10.1097/MNH.0b013e32835265ac CrossRefPubMed

21.

Tsubata Y, Akiyama F, Oya T, Ajiro J, Saeki T, Nishi S, Narita I (2010) IgG4-related chronic tubulointerstitial nephritis without autoimmune pancreatitis and the time course of renal function. Intern Med 49(15):1593–1598CrossRefPubMed

22.

Kawano M, Saeki T, Nakashima H, Nishi S, Yamaguchi Y, Hisano S, Yamanaka N, Inoue D, Yamamoto M, Takahashi H, Nomura H, Taguchi T, Umehara H, Makino H, Saito T (2011) Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol 15(5):615–626. doi:10.1007/s10157-011-0521-2 CrossRefPubMed

23.

Shoji S, Nakano M, Usui Y (2010) IgG4-related inflammatory pseudotumor of the kidney. Int J Urol 17(4):389–390. doi:10.1111/j.1442-2042.2010.02483.x CrossRefPubMed

24.

Saeki T, Kawano M (2014) IgG4-related kidney disease. Kidney Int 85(2):251–257. doi:10.1038/ki.2013.393 CrossRefPubMed

25.

Kawano M, Saeki T (2015) IgG4-related kidney disease—an update. Curr Opin Nephrol Hypertens 24(2):193–201. doi:10.1097/MNH.0000000000000102 PubMedCentralCrossRefPubMed

26.

Saeki T, Kawano M, Mizushima I, Yamamoto M, Wada Y, Nakashima H, Homma N, Tsubata Y, Takahashi H, Ito T, Yamazaki H, Saito T, Narita I (2013) The clinical course of patients with IgG4-related kidney disease. Kidney Int 84(4):826–833. doi:10.1038/ki.2013.191 CrossRefPubMed

27.

Nada R, Ramachandran R, Kumar A, Rathi M, Rawat A, Joshi K, Kohli HS, Gupta KL (2015) IgG4-related tubulointerstitial nephritis: a prospective analysis. Int J Rheum Dis. doi:10.1111/1756-185X.12675

28.

Seo N, Kim JH, Byun JH, Lee SS, Kim HJ, Lee MG (2015) Immunoglobulin G4-related kidney disease: a comprehensive pictorial review of the imaging spectrum, mimickers, and clinicopathological characteristics. Korean J Radiol 16(5):1056–1067. doi:10.3348/kjr.2015.16.5.1056 PubMedCentralCrossRefPubMed

29.

Kottra JJ, Dunnick NR (1996) Retroperitoneal fibrosis. Radiol Clin North Am 34(6):1259–1275PubMed

30.

Albarrán J (1905) Retention renale par peri-ureterite: liberation externe de l’uretere. Assoc Fr Urol 9:511–517

31.

Ormond JK (1948) Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process. J Urol 59(6):1072–1079PubMed

32.

Zen Y, Kasashima S, Inoue D (2012) Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease. Semin Diagn Pathol 29(4):212–218. doi:10.1053/j.semdp.2012.07.003 CrossRefPubMed

33.

Fujimori N, Ito T, Igarashi H, Oono T, Nakamura T, Niina Y, Hijioka M, Lee L, Uchida M, Takayanagi R (2013) Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol 19(1):35–41. doi:10.3748/wjg.v19.i1.35 PubMedCentralCrossRefPubMed

34.

Urban ML, Palmisano A, Nicastro M, Corradi D, Buzio C, Vaglio A (2015) Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach. Rev Med Interne 36(1):15–21. doi:10.1016/j.revmed.2014.10.008 CrossRefPubMed

35.

Mehta A, Blodgett TM (2011) Retroperitoneal fibrosis as a cause of positive FDG PET/CT. J Radiol Case Rep 5(7):35–41. doi:10.3941/jrcr.v5i7.722 PubMedCentralPubMed

36.

Chiba K, Kamisawa T, Tabata T, Hara S, Kuruma S, Fujiwara T, Kuwata G, Egashira H, Koizumi K, Koizumi S, Fujiwara J, Arakawa T, Momma K, Setoguchi K, Shinohara M (2013) Clinical features of 10 patients with IgG4-related retroperitoneal fibrosis. Intern Med 52(14):1545–1551CrossRefPubMed

37.

Koo BS, Koh YW, Hong S, Kim YJ, Kim YG, Lee CK, Yoo B (2015) Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis. Mod Rheumatol 25(2):194–198. doi:10.3109/14397595.2014.931908 CrossRefPubMed

38.

Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L, Ferretti S, Cobelli R, Moroni G, Dei Tos AP, Buzio C, Vaglio A (2007) Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int 72(6):742–753CrossRefPubMed

39.

Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R, Ferrozzi F, Corradi D, Salvarani C, Buzio C (2011) Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 378(9788):338–346. doi:10.1016/S0140-6736(11)60934-3 CrossRefPubMed

40.

Marando A, D’Ambrosio G, Catanzaro F, La Rosa S, Sessa F (2013) IgG4-related disease of the ureter: report of two cases and review of the literature. Virchows Arch 462(6):673–678. doi:10.1007/s00428-013-1421-5 CrossRefPubMed

41.

Kim SA, Lee SR, Huh J, Shen SS, Ro JY (2011) IgG4-associated inflammatory pseudotumor of ureter: clinicopathologic and immunohistochemical study of 3 cases. Hum Pathol 42(8):1178–1184. doi:10.1016/j.humpath.2010.03.011 CrossRefPubMed

42.

Kim S, Kim TG, Choi SK, Kim MJ, Min GE, Lee HL, Yoo KH (2013) Immunoglobulin g4-related systemic sclerosing disease: a case involving the ureter and kidney. Korean J Urol 54(3):209–211. doi:10.4111/kju.2013.54.3.209 PubMedCentralCrossRefPubMed

43.

Moriarty MA, Dahmoush L, Nepple KG (2014) IgG4 related disease of the ureter (inflammatory pseudotumor). J Urol 191(4):1126–1127. doi:10.1016/j.juro.2014.01.015 CrossRefPubMed

44.

Park S, Ro JY, Lee DH, Choi SY, Koo H (2013) Immunoglobulin G4-associated inflammatory pseudotumor of urinary bladder: a case report. Ann Diagn Pathol 17(6):540–543. doi:10.1016/j.anndiagpath.2013.01.004 CrossRefPubMed

45.

Montironi R, Scarpelli M, Cheng L, Lopez-Beltran A, Burattini M, Kirkali Z, Montorsi F (2013) Immunoglobulin G4-related disease in genitourinary organs: an emerging fibroinflammatory entity often misdiagnosed preoperatively as cancer. Eur Urol 64(6):865–872. doi:10.1016/j.eururo.2012.11.056 CrossRefPubMed

46.

Dropkin BM, Ingimarsson JP, Jones JD, Pettus JR, Seigne JD (2015) Immunoglobulin G4-related disease in the urinary bladder. Int J Urol 22(6):605–607. doi:10.1111/iju.12769 CrossRefPubMed

47.

Dum TW, Zhang D, Lee EK (2014) IgG4-related disease in a urachal tumor. Case Rep Urol 2014:275850. doi:10.1155/2014/275850 PubMedCentralPubMed

48.

Choi JW, Kim SY, Moon KC, Cho JY, Kim SH (2012) Immunoglobulin G4-related sclerosing disease involving the urethra: case report. Korean J Radiol 13(6):803–807. doi:10.3348/kjr.2012.13.6.803 PubMedCentralCrossRefPubMed

49.

Williamson SR, Scarpelli M, Lopez-Beltran A, Montironi R, Conces MR, Cheng L (2013) Urethral caruncle: a lesion related to IgG4-associated sclerosing disease? J Clin Pathol 66(7):559–562. doi:10.1136/jclinpath-2012-201218 CrossRefPubMed

50.

Migita K, Miyashita T, Mizuno A, Jiuchi Y, Ito M, Matsuo M, Izumi Y, Takeoka A, Nishino A, Hayashi M (2014) IgG4-related epididymo-orchitis associated with bladder cancer: possible involvement of BAFF/BAFF-R interaction in IgG4-related urogenital disease. Mod Rheumatol 24(1):188–194. doi:10.3109/14397595.2013.852841 CrossRefPubMed

51.

Yamanishi H, Kumagi T, Yokota T, Azemoto N, Koizumi M, Kobayashi Y, Abe M, Murakami H, Hiasa Y, Matsuura B, Kawamoto H, Yamamoto K, Onji M (2011) Clinical significance of B cell-activating factor in autoimmune pancreatitis. Pancreas 40(6):840–845. doi:10.1097/MPA.0b013e3182143b10 CrossRefPubMed

52.

de Buy Wenniger LM, Scheltema JM, Verheij J, Beuers U (2013) Testicular inflammation as a new manifestation of IgG4-associated disease. Urology 82(2):e15–e16. doi:10.1016/j.urology.2013.04.046 CrossRefPubMed

53.

Dieckmann KP, Struss WJ, Frey U, Nahler-Wildenhain M (2013) Paratesticular fibrous pseudotumor in young males presenting with histological features of IgG4-related disease: two case reports. J Med Case Rep 7:225. doi:10.1186/1752-1947-7-225 PubMedCentralCrossRefPubMed

54.

Bösmüller H, von Weyhern CH, Adam P, Alibegovic V, Mikuz G, Fend F (2011) Paratesticular fibrous pseudotumor—an IgG4-related disorder? Virchows Arch 458(1):109–113. doi:10.1007/s00428-010-0995-4 CrossRefPubMed

55.

Karashima T, Taniguchi Y, Shimamoto T, Nao T, Nishikawa H, Fukata S, Kamada M, Inoue K, Oko K, Nakajima H, Sano S, Matsumoto M, Kuroda N, Kamei Y, Shuin T (2014) IgG4-related disease of the paratestis in a patient with Wells syndrome: a case report. Diagn Pathol 9(1):225PubMedCentralCrossRefPubMed

56.

Hart PA, Moyer AM, Yi ES, Hogan MC, Pearson RK, Chari ST (2012) IgG4-related paratesticular pseudotumor in a patient with autoimmune pancreatitis and retroperitoneal fibrosis: an extrapancreatic manifestation of IgG4-related disease. Hum Pathol 43(11):2084–2087. doi:10.1016/j.humpath.2012.05.017 CrossRefPubMed

57.

Yoshimura Y, Takeda S, Ieki Y, Takazakura E, Koizumi H, Takagawa K (2006) IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med 45(15):897–901CrossRefPubMed

58.

Uehara T, Hamano H, Kawakami M, Koyama M, Kawa S, Sano K, Honda T, Oki K, Ota H (2008) Autoimmune pancreatitis-associated prostatitis: distinct clinicopathological entity. Pathol Int 58(2):118–125. doi:10.1111/j.1440-1827.2007.02199.x CrossRefPubMed

59.

Buijs J, de Buy Maillette, Wenniger L, van Leenders G, Verheij J, van Onna I, Hansen B, van Heerde M, Krak N, Beuers U, Bruno M, van Buuren H (2014) Immunoglobulin G4-related prostatitis: a case-control study focusing on clinical and pathologic characteristics. Urology 83(3):521–526. doi:10.1016/j.urology.2013.10.052 CrossRefPubMed

60.

Hart PA, Smyrk TC, Chari ST (2013) IgG4-related prostatitis: a rare cause of steroid-responsive obstructive urinary symptoms. Int J Urol 20(1):132–134. doi:10.1111/j.1442-2042.2012.03194.x CrossRefPubMed

61.

Nishimori I, Kohsaki T, Onishi S, Shuin T, Kohsaki S, Ogawa Y, Matsumoto M, Hiroi M, Hamano H, Kawa S (2007) IgG4-related autoimmune prostatitis: two cases with or without autoimmune pancreatitis. Intern Med 46(24):1983–1989CrossRefPubMed

62.

Bourlon MT, Sánchez-Ávila M, Chablé-Montero F, Arceo-Olaiz R (2013) IgG4-related autoimmune prostatitis: is it an unusual or underdiagnosed manifestation of IgG4-related disease? Case Rep Urol 2013:295472. doi:10.1155/2013/295472 PubMedCentralPubMed

63.

Nakai Y, Kagebayashi Y, Matsumoto Y, Fukui S, Kim Y, Yoshimoto S, Maruyama N, Samma S (2013) IgG4-related prostatitis associated with retroperitoneal fibrosis: a case report. Hinyokika Kiyo 59(12):781–784PubMed

64.

Aggarwal N, Parwani AV, Ho J, Cook JR, Swerdlow SH (2014) Plasma cell (Zoon) balanitis: another inflammatory disorder that can be rich in IgG4+ plasma cells. Am J Surg Pathol 38(10):1437–1443. doi:10.1097/PAS.0000000000000269 CrossRefPubMed

65.

Kotani S, Wakamatsu R, Itoh A, Miyamoto K, Yoshino M, Takami K, Ishihara S, Miura N, Banno S, Imai H (2012) Proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) positive IgG4-related retroperitoneal fibrosis: utility of PET-CT with 18F-fluorodeoxy glucose (FDG). Intern Med 51(7):755–758CrossRefPubMed

66.

Miyamoto H, Montgomery EA, Epstein JI (2010) Paratesticular fibrous pseudotumor: a morphologic and immunohistochemical study of 13 cases. Am J Surg Pathol 34(4):569–574. doi:10.1097/PAS.0b013e3181d438cb CrossRefPubMed

67.

Hirano K, Tada M, Sasahira N, Isayama H, Mizuno S, Takagi K, Watanabe T, Saito T, Kawahata S, Uchino R, Hamada T, Miyabayashi K, Mohri D, Sasaki T, Kogure H, Yamamoto N, Nakai Y, Yoshida H, Ito Y, Akiyama D, Toda N, Arizumi T, Yagioka H, Takahara N et al (2014) Incidence of malignancies in patients with IgG4-related disease. Intern Med 53(3):171–176CrossRefPubMed

68.

Horger M, Lamprecht HG, Bares R, Spira D, Schmalzing M, Claussen CD, Adam P (2012) Systemic IgG4-related sclerosing disease: spectrum of imaging findings and differential diagnosis. AJR Am J Roentgenol 199(3):W276–W282. doi:10.2214/AJR.11.8321 CrossRefPubMed

69.

Zhang J, Chen H, Ma Y, Xiao Y, Niu N, Lin W, Wang X, Liang Z, Zhang F, Li F, Zhang W, Zhu Z (2014) Characterizing IgG4-related disease with ¹⁸F-FDG PET/CT: a prospective cohort study. Eur J Nucl Med Mol Imaging 41(8):1624–1634. doi:10.1007/s00259-014-2729-3 PubMedCentralCrossRefPubMed

70.

Sharma P, Chatterjee P (2015) Contrast-enhanced (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in immunoglobulin G4-related retroperitoneal fibrosis. Indian J Nucl Med 30(1):72–74. doi:10.4103/0972-3919.147551 PubMedCentralCrossRefPubMed

71.

Jansen I, Hendriksz TR, Han SH, Huiskes AW, van Bommel EF (2010) (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med 21(3):216–221. doi:10.1016/j.ejim.2010.02.008 CrossRefPubMed

72.

Yamamoto M, Takahashi H, Tabeya T, Suzuki C, Naishiro Y, Ishigami K, Yajima H, Shimizu Y, Obara M, Yamamoto H, Himi T, Imai K, Shinomura Y (2012) Risk of malignancies in IgG4-related disease. Mod Rheumatol 22(3):414–418. doi:10.1007/s10165-011-0520-x CrossRefPubMed

73.

Shiokawa M, Kodama Y, Yoshimura K, Kawanami C, Mimura J, Yamashita Y, Asada M, Kikuyama M, Okabe Y, Inokuma T, Ohana M, Kokuryu H, Takeda K, Tsuji Y, Minami R, Sakuma Y, Kuriyama K, Ota Y, Tanabe W, Maruno T, Kurita A, Sawai Y, Uza N, Watanabe T, Haga H, Chiba T (2013) Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol 108(4):610–617. doi:10.1038/ajg.2012.465 CrossRefPubMed

Titel: IgG4-related disease: what urologists should know
verfasst von: Daniele Bianchi
Publikationsdatum: 01.03.2016
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 3/2016
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-015-1189-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Aim

Materials and methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2016

An unusual perineal mass in a male cyclist

New molecular insights in diabetic nephropathy

The impact of slow graft function on graft outcome is comparable to delayed graft function in deceased donor kidney transplantation

Neoplasm arising from the descended testis in a unilateral cryptorchid child: decisions and dilemmas

Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study

Saphenous vein sparing during laparoscopic bilateral inguinal lymphadenectomy for penile carcinoma patients